Skip Fleshman

Skip Fleshman is a partner at Asset Management Ventures who has invested in companies such as Proteus Digital Health, WellDoc, HealthTap, Evidation Health, Reify Health, Lark and Welkin. You can follow him on Twitter @skipfleshman and @amv.

By  Skip Fleshman 11:19 am January 22, 2021
Clinical trials have become big news this year amid the search for COVID-19 vaccines and treatments. They are a critical component of helping the FDA validate that new drugs and diagnostics will be both safe and effective. Pharmaceutical companies spend over $45B a year running clinical trials, which are, by design, very methodical and measured. Unfortunately, they are also slow, unpredictable...
By  Skip Fleshman 02:16 pm February 16, 2017
About the author: Skip Fleshman is a partner at Asset Management Ventures who has invested in companies such as Proteus Digital Health, WellDoc, HealthTap, Evidation Health, Reify Health, Lark and Welkin. You can follow him on Twitter @skipfleshman and @amv. Digital health technologies will transform healthcare. Mobile phones have given health care providers the ability to engage with patients 24...